Stock listing

NASDAQ:NCNA NuCana plc Stock

Follow NuCana plc into a list and get an email when it puts out news.

Share price · NASDAQ:NCNA

$0.75 USD -0.08 (-10.0%)

Close on Nov 20, 2026

Past year -78.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.703 – $0.79 USDNov 20, 2026
Volume
25,518 sharesNov 20, 2026
Market cap
$3.12M USDAt the close on Nov 20, 2026 · price × 4.16M shares outstanding
52-week range
$0.703 – $4.55 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$153,164 USDMedian day 27,524 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
NuCana plc logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NCNA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.75-0.083-10.0%$0.79$0.79$0.70325,518
$0.833-0.057-6.4%$0.841$0.86$0.8219,161
$0.89+0.027+3.1%$0.89$0.94$0.77443,311
$0.863-0.07-7.5%$0.938$0.94$0.86328,528
$0.933+0.003+0.3%$0.94$0.94$0.9312,764
$0.93-0.01-1.0%$0.912$0.93$0.87525,789
$0.94+0.005+0.5%$0.946$0.96$0.9041,526
$0.935-0.026-2.7%$0.972$0.972$0.93513,047
$0.961+0.023+2.4%$0.95$0.998$0.9513,831
$0.938+0.004+0.4%$0.948$0.95$0.90219,966
$0.934-0.086-8.4%$0.99$0.99$0.9027,524
$1.02+0.02+2.0%$1.03$1.087$0.98110,827
$1.00+0.02+2.0%$1.07$1.07$0.98513,906
$0.98-0.03-3.0%$1.02$1.039$0.9838,864
$1.01-0.03-2.9%$1.04$1.06$1.0019,200
$1.04-0.035-3.3%$1.07$1.085$1.0411,700
$1.075-0.025-2.3%$1.10$1.12$1.0631,100
$1.10+0.06+5.8%$1.05$1.17$1.0338,600
$1.04+0.055+5.6%$1.02$1.04$1.0027,100
$0.985+0.025+2.6%$0.98$1.02$0.9627,100
$0.96-0.002-0.2%$0.973$0.988$0.9531,800
$0.962-0.044-4.4%$1.00$1.01$0.96230,100
$1.006+0.029+3.0%$0.985$1.035$0.98329,300
$0.977-0.013-1.3%$0.998$1.015$0.97722,300
$0.99-0.03-2.9%$1.02$1.03$0.9746,700
$1.02-0.03-2.9%$1.02$1.038$0.9755,100
$1.050.000.0%$1.05$1.065$1.0338,000
$1.05-0.03-2.8%$1.10$1.10$1.0552,000
$1.08-0.02-1.8%$1.10$1.14$1.0828,600
$1.10-0.03-2.7%$1.13$1.18$1.0767,400
$1.13-0.01-0.9%$1.14$1.14$1.1034,600
$1.14+0.05+4.6%$1.11$1.18$1.0651,000
$1.09+0.03+2.8%$1.08$1.14$1.0550,900
$1.06-0.03-2.8%$1.12$1.12$1.0370,300
$1.09-0.08-6.8%$1.18$1.22$0.948320,900
$1.17-0.18-13.3%$1.29$1.313$1.01799,100
$1.35+0.14+11.6%$1.29$1.44$1.263,304,300
$1.21-0.08-6.2%$1.29$1.29$1.2124,700
$1.29+0.01+0.8%$1.32$1.37$1.2623,600
$1.28-0.04-3.0%$1.30$1.35$1.2138,200
$1.32+0.01+0.8%$1.31$1.34$1.2729,200
$1.31-0.02-1.5%$1.33$1.35$1.3027,800
$1.33+0.01+0.8%$1.348$1.38$1.3020,400
$1.32-0.02-1.5%$1.35$1.39$1.3225,300
$1.34+0.01+0.8%$1.33$1.385$1.3211,000
$1.33+0.03+2.3%$1.33$1.37$1.3047,200
$1.300.000.0%$1.31$1.332$1.3019,200
$1.30-0.02-1.5%$1.32$1.35$1.3065,600
$1.320.000.0%$1.34$1.37$1.31113,600
$1.32-0.02-1.5%$1.34$1.362$1.3225,100
$1.34-0.03-2.2%$1.36$1.375$1.3426,200
$1.37-0.03-2.1%$1.40$1.44$1.3717,100
$1.400.000.0%$1.42$1.43$1.4021,600
$1.40-0.03-2.1%$1.41$1.42$1.38332,200
$1.43+0.04+2.9%$1.38$1.44$1.36249,100
$1.39+0.01+0.7%$1.38$1.425$1.33150,700
$1.38-0.09-6.1%$1.44$1.45$1.355103,700
$1.47-0.29-16.5%$1.55$1.55$1.44192,900
$1.76+0.29+19.7%$1.45$1.90$1.411,018,300
$1.47-0.06-3.9%$1.50$1.51$1.4417,400
$1.53+0.06+4.1%$1.48$1.53$1.46512,800
$1.470.000.0%$1.47$1.55$1.4726,300
$1.47-0.05-3.3%$1.52$1.52$1.4713,400
$1.52-0.01-0.7%$1.50$1.55$1.5018,300
$1.53-0.02-1.3%$1.53$1.55$1.5018,400

Splits

2 splits since 2024 · NASDAQ:NCNA · every price before a split is adjusted for it

DayRatioWhat
1-for-200Consolidation
1-for-25Consolidation
Ticker
NASDAQ:NCNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All NuCana plc news

NuCana plc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Nov 20, 2026 · oldest 2026
Decks
1 deck · latest October 2026

Valuation

Price/book 0.1× against a median of 0.7×: 2nd lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
−$21.37M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.58

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NuCana plc · NASDAQ:NCNAUS$3.12M−US$21.37Mn/an/an/a0.1×n/a0.0×1.58
Xenetic Biosciences, Inc. · NASDAQ:XBIOUS$3.28M−US$2.53Mn/a−0.8×n/a0.7×−123.7%0.0×1.46
Aprea Therapeutics, Inc. · NASDAQ:APREUS$3.25M−US$34.60Mn/an/an/a0.1×n/a0.0×0.73
Spago Nanomedical AB · OMXSTO:SPAGOUS$3.20MUS$22,063n/a5.6×n/a1.0×n/a0.0×n/a
Kiora Pharmaceuticals, Inc. · NASDAQ:KPRXUS$3.19M−US$12.81Mn/a−12.8×n/a0.2×n/a0.0×1.54
Azitra Inc · AMEX:AZTRUS$3.13M−US$618,677n/an/an/a0.7×n/a0.0×0.60
Revive Therapeutics Ltd. · CSE:RVVUS$3.10MUS$3.14Mn/an/an/an/an/an/a0.56
Skye Bioscience, Inc. · NASDAQ:SKYEUS$3.10M−US$1.71Mn/an/an/a2.3×n/a0.0×0.85
Creative Medical Technology Holdings, Inc. · NASDAQ:CELZUS$3.06M−US$3.79Mn/a−1,263×n/a0.4×n/a0.0×1.53
Oncology Pharma Inc. · OTC:ONPHUS$3.04Mn/an/an/an/an/an/an/a1.62
Imunon, Inc. · NASDAQ:IMNNUS$3.00MUS$5.90Mn/an/an/a1.1×n/a2.6×0.57
Median of the othersUS$3.12M−US$1.71M−6.8×0.7×−123.7%0.0×0.85

Forecasts

Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
104.00 USD · Analysts' mean
EPS, year to Dec 2024
-12.55 · 1 analyst

Team and board

Officers

OfficerRole
Hugh GriffithFounder, CEO & Board Member
Ian WebsterChief Financial Officer
Theresa BruceChief Operating Officer
Jeffrey BlossChief Medical Officer

Board

DirectorRole
Andrew KayChairman
Cyrille LeperlierNon Executive Director
Elliott LevyNon Executive Director
Hugh GriffithFounder, CEO & Board Member
Martin MellishNon Executive Director

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 12, 2026−0.8%
Q2 2026Aug 13, 2026+11.2%
Q3 2025Nov 13, 2025−10.0%
Q2 2025Aug 20, 2025−7.0%
Q1 2025May 14, 2025 · Before open+5.2%
Q4 2024Mar 20, 2025 · After close−2.2%
Q3 2024Nov 25, 2024 · Before open+2.4%
Q2 2024Aug 15, 2024 · After close+6.4%
Q1 2024May 16, 2024 · After close−2.7%
Q4 2023Mar 20, 2024 · After close−12.9%
All 20 quarters
QuarterResultsShare move
Q3 2023Nov 16, 2023 · After close+1.7%
Q2 2023Aug 16, 2023 · After close+9.9%
Q1 2023May 17, 2023 · After close−2.6%
Q4 2022Mar 22, 2023−14.4%
Q3 2022Nov 16, 2022 · After close−6.6%
Q2 2022Aug 17, 2022 · After close−4.3%
Q1 2022Jun 2, 2022 · After close+0.7%
Q3 2021Nov 18, 2021 · After close+3.5%
Q2 2021Aug 19, 2021 · After close0.0%
Q1 2021May 19, 2021 · After close+1.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck41 slidesOctober 2026

Open Decks

IPO

Priced at US$15.00 an ADS on Sep 27, 2017.

Price
US$15.00 an ADS
ADSs offered
6,667,000 American depositary shares
Offering size
US$100 million
Underwriters' option
Up to 1,000,050 more ADSs
Underwriters
Citigroup, Jefferies, Cowen, William Blair · In the order on the cover
ADSs delivered
On or about Oct 2, 2017

Steps

StepWhen
Draft sent to the SEC in confidenceJun 26, 2017
Filed publiclySep 1, 2017
Amended twiceNewest Sep 21, 2017
Shares registered with an exchangeSep 22, 2017
Declared effective by the SECSep 27, 2017
Final prospectus, with the priceSep 29, 2017

Open IPO · From the cover of the final prospectus (424B4) filed Sep 29, 2017

Financials

Annual, in GBP

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue00000000283.0K0
Cost of revenue268.0K0000
Gross profit-268.0K00283.0K0
Research and development12.7M18.0M25.1M36.4M36.8M25.9M19.7M16.8M17.7M7.90M
Selling, general and administrative8.10M4.99M6.06M7.29M8.53M7.05M5.95M5.18M4.57M1.14M
Operating income-20.1M-22.8M-32.8M-39.1M-47.9M-36.4M-26.7M-19.1M-25.7M-8.45M
Depreciation and amortization274.0K522.0K575.0K732.0K942.0K890.0K718.0K371.0K194.0K101.0K
EBITDA-19.8M-22.3M-32.2M-38.4M-47.0M-35.5M-26.0M-18.8M-25.5M-8.35M
Interest expense12.6M009.86M4.98M6.70M989.0K01.79M0
Income before tax-30.5M-22.5M-32.0M-38.5M-47.8M-36.2M-25.7M-18.1M-25.5M-8.16M
Income tax-1.17M-3.45M-4.40M-6.43M-7.27M-5.49M-4.24M-4.22M-2.40M-2.12M
Net income-29.4M-19.0M-27.6M-32.0M-40.5M-30.7M-21.4M-13.8M-23.1M-6.05M
Earnings per share, basic0.00-0.26-0.53-0.61-0.78-4,049.89-3,311.99-2,164.53-3,686.52-950.80
Earnings per share, diluted0.00-0.26-0.53-0.61-0.78

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents24.3M6.75M17.2M41.9M60.3M87.4M52.0M77.0M86.7M20.0M
Short-term investments0000
Receivables849.0K922.0K2.67M3.96M4.16M4.63M4.71M2.35M3.05M2.61M
Inventory-11.3K-14.4K-13.2K-1.80M-3.05M3.20M
Current assets26.9M12.3M25.0M54.9M71.6M101.8M65.2M83.6M94.0M25.8M
Property, plant and equipment658.0K197.0K521.0K866.0K851.0K1.19M1.11M427.0K358.0K18.0K
Goodwill0000
Total assets29.8M14.8M27.8M58.3M77.5M107.8M70.3M87.2M96.4M27.2M
Accounts payable522.0K2.71M3.38M4.80M1.83M2.26M2.41M2.46M1.12M728.0K
Current liabilities4.79M8.67M12.7M19.3M11.7M8.15M6.18M5.57M2.92M1.97M
Long-term debt0000
Total debt676.0K190.0K396.0K639.0K371.0K645.0K806.0K000
Total liabilities5.51M8.82M12.9M19.8M11.9M8.56M6.75M5.59M2.94M1.97M
Shareholders' equity24.3M5.95M14.9M38.5M65.5M99.2M63.5M81.6M93.4M25.2M
Shares outstanding2.25M14.8K10.5K10.4K10.4K7.58K6.46K6.39K6.26K6.36K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-7.47M-19.1M-26.4M-23.2M-23.8M-21.6M-23.8M-12.2M-8.71M-9.26M
Capital spending0-4.00K-4.00K-12.0K-64.0K-361.0K-46.0K-210.0K-370.0K-15.0K
Free cash flow-7.47M-19.1M-26.4M-23.2M-23.9M-22.0M-23.9M-12.4M-9.08M-9.28M
Cash from investing159.0K79.0K2.89M120.0K-3.56M-1.31M-145.0K-651.0K-933.0K14.9M
Cash from financing25.0M8.18M-53.0K-161.0K-98.0K61.8M-47.0K207.0K77.7M200.0K
Dividends paid0000
Share buybacks125.0K207.0K80.0M200.0K
Change in cash17.7M-10.9M-23.6M-23.2M-27.5M38.9M-24.0M-12.7M68.1M5.87M

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 20, 2026Current reportSEC
6-K · Report of a foreign issuerNov 12, 2026Current reportSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
6-K · Report of a foreign issuerAug 13, 2026Current reportSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
6-K · Report of a foreign issuerJun 8, 2026Current reportSEC
6-K · Report of a foreign issuerJun 1, 2026Current reportSEC
6-K · Report of a foreign issuerMay 14, 2026Current reportSEC
6-K · Report of a foreign issuerMay 6, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipApr 16, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 1, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 20, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 19, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 19, 2026Offer documentSEC
20-F · Annual reportMar 19, 2026Annual reportSEC
6-K · Report of a foreign issuerMar 19, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeMar 18, 2026Big-stake noticeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
6-K · Report of a foreign issuerJan 6, 2026Current reportSEC
6-K · Report of a foreign issuerDec 17, 2025Current reportSEC
6-K · Report of a foreign issuerDec 10, 2025Current reportSEC
6-K · Report of a foreign issuerNov 13, 2025Current reportSEC
6-K · Report of a foreign issuerNov 5, 2025Current reportSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 14, 2025Current reportSEC
6-K · Report of a foreign issuerSep 5, 2025Current reportSEC
6-K · Report of a foreign issuerSep 3, 2025Current reportSEC
6-K · Report of a foreign issuerAug 20, 2025Current reportSEC
6-K · Report of a foreign issuerAug 1, 2025Current reportSEC
6-K · Report of a foreign issuerJul 21, 2025Current reportSEC
F-6 POSJul 16, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 11, 2025Current reportSEC
6-K · Report of a foreign issuerJul 9, 2025Current reportSEC
6-K · Report of a foreign issuerJun 30, 2025Current reportSEC
424B5 · ProspectusJun 27, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 27, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJun 25, 2025Other filingsSEC
CORRESP · Letter to the SECJun 20, 2025Other filingsSEC
6-K · Report of a foreign issuerJun 20, 2025Current reportSEC
F-3/A · Registration statement, amendedJun 18, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 18, 2025Current reportSEC
UPLOAD · Letter from the SECJun 13, 2025Other filingsSEC
6-K · Report of a foreign issuerJun 5, 2025Current reportSEC
6-K · Report of a foreign issuerJun 2, 2025Current reportSEC
424B4 · ProspectusMay 7, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 6, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveMay 6, 2025Other filingsSEC
CORRESP · Letter to the SECMay 5, 2025Other filingsSEC
CORRESP · Letter to the SECMay 5, 2025Other filingsSEC
CORRESP · Letter to the SECMay 1, 2025Other filingsSEC
CORRESP · Letter to the SECMay 1, 2025Other filingsSEC
F-1/A · Registration statement, amendedMay 1, 2025Offer documentSEC
CORRESP · Letter to the SECApr 29, 2025Other filingsSEC
CORRESP · Letter to the SECApr 29, 2025Other filingsSEC
CORRESP · Letter to the SECApr 29, 2025Other filingsSEC
F-1/A · Registration statement, amendedApr 29, 2025Offer documentSEC
UPLOAD · Letter from the SECApr 24, 2025Other filingsSEC
F-6Apr 24, 2025Other filingsSEC
DRSLTR · Letter to the SEC with a draftApr 24, 2025Other filingsSEC
F-1 · Registration statementApr 24, 2025Offer documentSEC
6-K · Report of a foreign issuerApr 23, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 18, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECApr 17, 2025Other filingsSEC
DRS · Draft registration statementApr 4, 2025Offer documentSEC
20-F · Annual reportMar 20, 2025Annual reportSEC
6-K · Report of a foreign issuerMar 20, 2025Current reportSEC
6-K · Report of a foreign issuerMar 18, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 25, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 10, 2025Current reportSEC
6-K · Report of a foreign issuerNov 25, 2024Current reportSEC
6-K · Report of a foreign issuerNov 12, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedOct 4, 2024Big-stake noticeSEC
424B5 · ProspectusOct 1, 2024Offer documentSEC
6-K · Report of a foreign issuerSep 30, 2024Current reportSEC
6-K · Report of a foreign issuerSep 26, 2024Current reportSEC
6-K · Report of a foreign issuerSep 16, 2024Current reportSEC
6-K · Report of a foreign issuerAug 29, 2024Current reportSEC
UPLOAD · Letter from the SECAug 19, 2024Other filingsSEC
F-3 · Registration statementAug 15, 2024Offer documentSEC
6-K · Report of a foreign issuerAug 15, 2024Current reportSEC
6-K · Report of a foreign issuerJun 18, 2024Current reportSEC
6-K · Report of a foreign issuerMay 16, 2024Current reportSEC
6-K · Report of a foreign issuerMay 13, 2024Current reportSEC
6-K · Report of a foreign issuerMay 1, 2024Current reportSEC
6-K · Report of a foreign issuerApr 16, 2024Current reportSEC
6-K · Report of a foreign issuerApr 9, 2024Current reportSEC
F-6 POSMar 27, 2024Other filingsSEC
424B5 · ProspectusMar 27, 2024Offer documentSEC
6-K · Report of a foreign issuerMar 27, 2024Current reportSEC
20-F · Annual reportMar 20, 2024Annual reportSEC
6-K · Report of a foreign issuerMar 20, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedFeb 27, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 26, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerNov 16, 2023Current reportSEC
6-K · Report of a foreign issuerNov 13, 2023Current reportSEC
6-K · Report of a foreign issuerOct 16, 2023Current reportSEC
6-K · Report of a foreign issuerOct 13, 2023Current reportSEC
6-K · Report of a foreign issuerSep 18, 2023Current reportSEC
6-K · Report of a foreign issuerAug 16, 2023Current reportSEC
6-K · Report of a foreign issuerJun 16, 2023Current reportSEC
6-K · Report of a foreign issuerMay 17, 2023Current reportSEC
6-K · Report of a foreign issuerMay 15, 2023Current reportSEC
6-K · Report of a foreign issuerMay 12, 2023Current reportSEC
6-K · Report of a foreign issuerApr 14, 2023Current reportSEC
20-F · Annual reportApr 4, 2023Annual reportSEC
6-K · Report of a foreign issuerApr 4, 2023Current reportSEC
6-K · Report of a foreign issuerMar 24, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 23, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerJan 23, 2023Current reportSEC
6-K · Report of a foreign issuerJan 6, 2023Current reportSEC
6-K · Report of a foreign issuerNov 16, 2022Current reportSEC
6-K · Report of a foreign issuerOct 26, 2022Current reportSEC
6-K · Report of a foreign issuerSep 12, 2022Current reportSEC
6-K · Report of a foreign issuerSep 12, 2022Current reportSEC
6-K · Report of a foreign issuerSep 6, 2022Current reportSEC
6-K · Report of a foreign issuerAug 17, 2022Current reportSEC
SC 13D/A · Big-stake notice, amendedAug 11, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerJul 27, 2022Current reportSEC
6-K · Report of a foreign issuerJul 11, 2022Current reportSEC
6-K · Report of a foreign issuerJun 23, 2022Current reportSEC
6-K · Report of a foreign issuerJun 10, 2022Current reportSEC
6-K · Report of a foreign issuerJun 3, 2022Current reportSEC
6-K · Report of a foreign issuerJun 2, 2022Current reportSEC
6-K · Report of a foreign issuerMay 23, 2022Current reportSEC
20-F · Annual reportApr 27, 2022Annual reportSEC
6-K · Report of a foreign issuerApr 27, 2022Current reportSEC
6-K · Report of a foreign issuerMar 8, 2022Current reportSEC
6-K · Report of a foreign issuerMar 2, 2022Current reportSEC
SC 13D/A · Big-stake notice, amendedFeb 25, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 22, 2022Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 27, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerNov 18, 2021Current reportSEC
6-K · Report of a foreign issuerNov 1, 2021Current reportSEC
6-K · Report of a foreign issuerSep 29, 2021Current reportSEC
6-K · Report of a foreign issuerSep 16, 2021Current reportSEC
6-K · Report of a foreign issuerSep 15, 2021Current reportSEC
EFFECT · Notice that a registration is effectiveAug 30, 2021Other filingsSEC
CORRESP · Letter to the SECAug 25, 2021Other filingsSEC
UPLOAD · Letter from the SECAug 25, 2021Other filingsSEC
F-3 · Registration statementAug 19, 2021Offer documentSEC
6-K · Report of a foreign issuerAug 19, 2021Current reportSEC
6-K · Report of a foreign issuerAug 10, 2021Current reportSEC
6-K · Report of a foreign issuerJun 25, 2021Current reportSEC
SC 13D/A · Big-stake notice, amendedJun 15, 2021Big-stake noticeSEC
6-K · Report of a foreign issuerMay 24, 2021Current reportSEC
6-K · Report of a foreign issuerMay 19, 2021Current reportSEC
6-K · Report of a foreign issuerApr 19, 2021Current reportSEC
6-K · Report of a foreign issuerApr 12, 2021Current reportSEC
SC 13G/A · Big-stake notice, amendedMar 8, 2021Big-stake noticeSEC
20-F · Annual reportMar 4, 2021Annual reportSEC
6-K · Report of a foreign issuerMar 4, 2021Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 26, 2021Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 16, 2021Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 16, 2021Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2021Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2021Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedFeb 2, 2021Big-stake noticeSEC
SC 13G · Big-stake noticeJan 28, 2021Big-stake noticeSEC
6-K · Report of a foreign issuerJan 15, 2021Current reportSEC
6-K · Report of a foreign issuerDec 22, 2020Current reportSEC
6-K · Report of a foreign issuerNov 30, 2020Current reportSEC
6-K · Report of a foreign issuerNov 19, 2020Current reportSEC
SC 13D/A · Big-stake notice, amendedOct 28, 2020Big-stake noticeSEC
6-K · Report of a foreign issuerOct 13, 2020Current reportSEC
SC 13D/A · Big-stake notice, amendedOct 2, 2020Big-stake noticeSEC
SC 13D · Big-stake noticeSep 28, 2020Big-stake noticeSEC
6-K · Report of a foreign issuerSep 21, 2020Current reportSEC
6-K · Report of a foreign issuerSep 18, 2020Current reportSEC
424B5 · ProspectusSep 17, 2020Offer documentSEC
6-K · Report of a foreign issuerSep 16, 2020Current reportSEC
424B5 · ProspectusSep 16, 2020Offer documentSEC
S-8 · Registration statement for employee plansAug 19, 2020Offer documentSEC
6-K · Report of a foreign issuerAug 19, 2020Current reportSEC
6-K · Report of a foreign issuerJun 26, 2020Current reportSEC
SC 13G/A · Big-stake notice, amendedJun 11, 2020Big-stake noticeSEC
6-K · Report of a foreign issuerJun 2, 2020Current reportSEC
6-K · Report of a foreign issuerMay 19, 2020Current reportSEC
6-K · Report of a foreign issuerMay 18, 2020Current reportSEC
6-K · Report of a foreign issuerMay 15, 2020Current reportSEC
6-K · Report of a foreign issuerMay 5, 2020Current reportSEC
6-K · Report of a foreign issuerApr 2, 2020Current reportSEC
20-F · Annual reportMar 10, 2020Annual reportSEC
6-K · Report of a foreign issuerMar 10, 2020Current reportSEC
SC 13G/A · Big-stake notice, amendedMar 10, 2020Big-stake noticeSEC
6-K · Report of a foreign issuerMar 4, 2020Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2020Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2020Big-stake noticeSEC

This page holds 200 of 284 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from NuCana plc’s releases

Common shares
4,161,971
Fully diluted
4,161,971

Fully diluted

LineShares
Common shares4,161,971

Share count over time

CountShares
Nov 22, 20264,161,971

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Hrt Financial LP22,4960.54%US$30,000Sep 30, 2026
StoneX Group Inc.17,2970.42%US$24,461Sep 30, 2026
Glass Jacobson Investment Advisors llc15,0000.36%US$20,250Sep 30, 2026
Citadel12,0350.29%US$16,247Sep 30, 2026
Rhumbline Advisers4,6980.11%US$6,339Sep 30, 2026
Citigroup Inc1,1250.03%US$1,519Sep 30, 2026
Nuveen5390.01%US$652Sep 30, 2026
Tower Research Capital LLC (TRC)20<0.01%US$27Sep 30, 2026
Caitong International Asset Management Co., Ltd6<0.01%US$8Sep 30, 2026
Morgan Stanley2<0.01%US$3Sep 30, 2026
All 12 holders
HolderSharesOf the companyValueAs of
Acadian Asset Management LLC2<0.01%Sep 30, 2026
SBI Securities Co., Ltd.1<0.01%US$1Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Elliott Levy
Other companies: Editas Medicine, Inc. (Director · Since at least Apr 11, 2023); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 20, 2024 · Past)
Non Executive Director · Since at least Mar 18, 2026
Andrew KayChairman · Since at least Nov 5, 2026
Cyrille LeperlierDirector · Since at least Mar 18, 2026
David James HarrisonHead of Translational Medicine · Since at least Mar 18, 2026
Hugh GriffithChief Executive Officer, Director · Since at least Mar 18, 2026
Ian WebsterChief Financial Officer · Since at least Nov 5, 2026
Jeffrey BlossChief Medical Officer · Since at least Mar 18, 2026
Martin MellishNon Executive Director · Since at least Nov 5, 2026
Theresa BruceChief Operating Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about NuCana plc.